Premier Alternatives

Origin Endoscopy

Englewood, CO · Founded 2022 · Privately Held (backing)

Developer of endoscopy products designed to control gastrointestinal bleeding. Origin Endoscopy is based in Englewood, CO and was founded in 2022. It was valued at $8 million at its seed round in Jun 2025, the last priced event on record. It has raised $2.3 million across 1 recorded round; the latest was a $2.3 million seed round in Sep 2024.

PMV mark · valuation
$8.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$2.3M
Last round
Seed Round
Sep 2024

Origin Endoscopy key facts

as of Oct 2026
  • Developer of endoscopy products designed to control gastrointestinal bleeding.
  • Origin Endoscopy is valued at approximately $8.0M as of Oct 2026, set at its seed round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $2.3M across 1 recorded rounds; the latest was Seed Round ($2.3M) in Sep 2024.
  • Notable investors include Innosphere Ventures, Highpoint Ventures, Johns Hopkins Technology Ventures, Monarc Partners.
  • Origin Endoscopy has filed 3 Form Ds with the SEC since 2024, most recently Jun 2025 ($2.3M sold to 5 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$8.0M

Valued at $8.0M at its seed round, Jun 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Origin Endoscopy with a free account
  • ·Watch Origin Endoscopy: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Origin Endoscopy funding rounds

1 rounds
Sep 2024Seed Round$2.3MSEC filing▮
Full funding history →

Origin Endoscopy valuation

Origin Endoscopy was valued at $8 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Origin Endoscopy raised?

Origin Endoscopy has raised $2.3 million across 1 recorded round since 2024. The largest was a $2.3 million seed round in Sep 2024.

Origin Endoscopy has filed 3 Form Ds with the SEC since 2024, most recently in Jun 2025 ($2.3 million sold to 5 investors).

Origin Endoscopy investors

4 investors are on record for Origin Endoscopy, including Innosphere Ventures, Highpoint Ventures, Johns Hopkins Technology Ventures and Monarc Partners. The seed round in Sep 2024 drew 5 investors.

About Origin Endoscopy

Developer of endoscopy products designed to control gastrointestinal bleeding. The company specializes in diagnostics and reducing bleeding after a polyp procedure focusing on lower bowel and seal wounds, providing doctors with patient outcomes for procedures such as endoscopic mucosal or submucosal dissection.

Sector
Healthcare
HQ
Englewood, CO, United States
Founded
2022
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.